Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Plaque Psoriasis Management: Evaluating Non-Steroidal Treatments and Current Data Trends : Episode 13
When to Discontinue Treatment: Interpreting Safety Signals and Adverse Event Patterns
Key opinion leaders examine safety concerns and adverse event trends in psoriasis treatments, discussing how these factors influence decisions to discontinue therapy and transition patients to alternative interventions.
EP: 1.Navigating Plaque Psoriasis: Insights into the Psychosocial Impact and Evolving Treatment Landscape
EP: 2.Plaque Psoriasis Case Study: Patient Presentation, Treatment Selection, and Shared Decision-Making for Improved Outcomes
EP: 3.Empowering Patients with Plaque Psoriasis: Navigating Treatment Challenges Informed Patient Conversations and Decision Trees
EP: 4.A Conversation on Combination Therapy, Safety Profiles, and Targeted IL-17 Systemic Treatments
EP: 5.Clinical Insights: Managing Psoriasis Treatment Dynamics and Strategic Therapy Switching Considerations
EP: 6.Head-to-Head Clinical Trials: Comparing Psoriasis Treatment Response Rates
EP: 7.TYK2 Inhibition and Deucravacitinib: Mechanism of Action, Safety Considerations, and Patient-Provider Conversations
EP: 8.Comparative Analysis: Deucravacitinib and Adalimumab in Psoriasis Treatment
EP: 9.Understanding IL-17 Therapies: Treatment Considerations, Rapid Response, and Impact on Plaque Psoriasis Location
EP: 10.Expert Insights into Managing Inadequate Response to Systemic Therapies: Strategies and Solutions
EP: 11.Long-Term Efficacy and Insights from POETYK PSO-1 Studies: Implications for Psoriasis Treatment
EP: 12.Achieving Durable Responses: Physician's Guide to Interpreting Long-Term Efficacy Data
Now Viewing
EP: 13.When to Discontinue Treatment: Interpreting Safety Signals and Adverse Event Patterns
EP: 14.Updating Treatment Guidelines: Incorporating Novel Therapies to Address Unmet Needs
Recent Videos
Related Content
